Select Medical Holdings (SEM) Tops Q3 EPS by 10c; offers guidance

Select Medical Holdings (NYSE: SEM) reported Q3 EPS of $0.50, $0.10 better than the analyst estimate of $0.40. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.74 billion.

GUIDANCE:

Select Medical Holdings sees FY2024 EPS of $2.09-$2.20, versus the consensus of $2.09. Select Medical Holdings sees FY2024 revenue of $6.95-7.15 billion, versus the consensus of $7.029 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Deutsche Bank Upgrades Softbank Group Corp. (9984:JP) (SFTBY) to Buy
• Select Medical stockholders approve buyout by insider-led consortium